Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk-Reference-Cited by-同舟云学术

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

Published:2017-11-28 Issue:18 Volume:31 Page:2503-2514
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Gatell José M.,Assoumou Lambert,Moyle Graeme,Waters Laura,Johnson Margaret,Domingo Pere,Fox Julie,Martinez Esteban,Stellbrink Hans–Jürgen,Guaraldi Giovanni,Masia Mar,Gompels Mark,De Wit Stephane,Florence Eric,Esser Stefan,Raffi François,Pozniak Anton L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference51 articles.

1. Backbones versus core agents in initial ART regimens: one game, two players;Llibre;J Antimicrob Chemother,2016

2. Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572);Hare;Mol Pharmacol,2011

3. Hit me with your best shot: dolutegravir: a space in the next WHO guidelines?;Cohn;AIDS,2015

4. Dolutegravir: a review of the pharmacology, efficacy, and safety in the treatment of HIV;Kandel;Drug Des Devel Ther,2015

5. Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study;Martinez;AIDS,2010

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations on the Associations Between Antiretroviral Regimen and Changes in Blood Pressure in the D2EFT Study;Clinical Infectious Diseases;2024-06-29

2. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17

3. The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease;Clinical Cardiology;2024-05

4. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review;Viruses;2024-03-04

5. Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor–Based Three-Drug Antiretroviral Therapy;Journal of Pharmacy Technology;2024-01-19